The causal relationship between asthma and chronic obstructive pulmonary disease based on a two-sample Mendelian randomization analysis

Li Yalan, Zhang Wei, Sun Shiqi, Jiang Linhong, Chen Feng

PDF(4387 KB)
PDF(4387 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (08) : 1012-1017. DOI: 10.13406/j.cnki.cyxb.003564
Bioinformatics

The causal relationship between asthma and chronic obstructive pulmonary disease based on a two-sample Mendelian randomization analysis

Author information +
History +

Abstract

Objective To investigate whether there is a causal relationship between asthma and chronic obstructive pulmonary disease(COPD) using the two-sample Mendelian randomization(MR) approach. Methods Single nucleotide polymorphisms(SNPs) strongly associated with asthma were obtained as instrumental variables(IVs) from the pooled data of genome-wide association studies,and the inverse variance weighted(IVW) method was used as the main analytical method,assisted by the methods of MR-Egger,weighted median,simple model,and weighted model,to evaluate the causal relationship between asthma and the risk of COPD. At the same time,the MR-PRESSO test was used to detect whether there was an outlier SNP,and the MR-Egger intercept test and the Cochran Q test were used to evaluate the horizontal pleiotropy and heterogeneity of IVs. Results A total of 61 SNPs were included,and IVW results showed that asthma is a risk factor for COPD.(odds ratio[OR]=1.146,95%CI=1.023-1.283,P=0.020; OR=1.153,95% CI=1.003-1.326,P=0.045),and the results of the other four auxiliary analysis methods were consistent with the results of IVW. The results of the MR-PRESSO test,the Cochran Q test,the MR-Egger intercept test,and the leave-one-out method all showed the stability of the above results. Conclusion Asthma may increase the risk of COPD.

Key words

asthma / chronic obstructive pulmonary disease / Mendelian randomization / genome-wide association studies

Cite this article

Download Citations
Li Yalan , Zhang Wei , Sun Shiqi , et al . The causal relationship between asthma and chronic obstructive pulmonary disease based on a two-sample Mendelian randomization analysis. Journal of Chongqing Medical University. 2024, 49(08): 1012-1017 https://doi.org/10.13406/j.cnki.cyxb.003564

References

1
Collaborators GCRD . Prevalence and attributable health burden of chronic respiratory diseases,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med20208(6):585-596.
2
Wang C Xu JY Yang L,et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J]. Lancet2018391(10131):1706-1717.
3
Larsson SC Burgess S. Causal role of high body mass index in multiple chronic diseases:a systematic review and meta-analysis of Mendelian randomization studies[J]. BMC Med202119(1):320.
4
Cheng XX Shi J Zhang D,et al. Assessing the genetic relationship between gastroesophageal reflux disease and chronic respiratory diseases:a Mendelian randomization study[J]. BMC Pulm Med202323(1):243.
5
Joo H Park SY Park SY,et al. Phenotype of asthma-COPD overlap in COPD and severe asthma cohorts[J]. J Korean Med Sci202237(30):e236.
6
Shirtcliffe P Marsh S Travers J,et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease[J]. Intern Med J201242(1):83-88.
7
Hayden LP Hobbs BD Cohen RT,et al. Childhood pneumonia increases risk for chronic obstructive pulmonary disease:the COPDGene study[J]. Respir Res201516(1):115.
8
Deolmi M Decarolis NM Motta M,et al. Early origins of chronic obstructive pulmonary disease:prenatal and early life risk factors[J]. Int J Environ Res Public Health202320(3):2294.
9
Asamoah-Boaheng M Acheampong L Tenkorang EY,et al. Association between early history of asthma and COPD diagnosis in later life:a systematic review and meta-analysis[J]. Int J Epidemiol201847(6):1865-1876.
10
Asamoah-Boaheng M Farrell J Bonsu KO,et al. Association between medication adherence and risk of COPD in adult asthma patients:a retrospective cohort study in Canada[J]. Clin Epidemiol202214:1241-1254.
11
Davey Smith G Hemani G. Mendelian randomization:genetic anchors for causal inference in epidemiological studies[J]. Hum Mol Genet201423(R1):89-98.
12
VanderWeele TJ Tchetgen Tchetgen EJ Cornelis M,et al. Methodological challenges in Mendelian randomization[J]. Epidemiology201425(3):427-435.
13
Braido F Scichilone N Lavorini F,et al. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease:an Interasma(Global Asthma Association-GAA) and World Allergy Organization(WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma(ARIA) and Global Allergy and Asthma European Network(GA2LEN)[J]. World Allergy Organ J20169(1):37.
14
Hogg JC Chu F Utokaparch S,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease[J]. N Engl J Med2004350(26):2645-2653.
15
Ali KM. Childhood asthma as a risk factor for adult chronic obstructive pulmonary disease:a systematic review and meta-analysis[J]. Expert Rev Respir Med2020:1-7.
16
Yang WC Li FY Li C,et al. Focus on early COPD:definition and early lung development[J]. Int J Chron Obstruct Pulmon Dis202116:3217-3228.
17
Weingaertner V Scheve C Gerdes V,et al. Breathlessness,functional status,distress,and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer:a cohort study[J]. J Pain Symptom Manage201448(4):569-581.
18
Barnes PJ. Cellular and molecular mechanisms of asthma and COPD[J]. Clin Sci2017131(13):1541-1558.
19
Banno A Reddy AT Lakshmi SP,et al. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma[J]. Clin Sci2020134(9):1063-1079.
20
Guo P Li R Piao TH,et al. Pathological mechanism and targeted drugs of COPD[J]. Int J Chron Obstruct Pulmon Dis202217:1565-1575.
21
Raby KL Michaeloudes C Tonkin J,et al. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD[J]. Front Immunol202314:1201658.
22
Caramori G Ruggeri P Di Stefano A,et al. Autoimmunity and COPD:clinical implications[J]. Chest2018153(6):1424-1431.
23
Bu T Wang LF Yin YQ. How do innate immune cells contribute to airway remodeling in COPD progression?[J]. Int J Chron Obstruct Pulmon Dis202015:107-116.
24
Caramori G Casolari P Barczyk A,et al. COPD immunopathology[J]. Semin Immunopathol201638(4):497-515.

Comments

PDF(4387 KB)

Accesses

Citation

Detail

Sections
Recommended

/